MONTREAL, April 10, 2019 (GLOBE NEWSWIRE) – I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management is proud to announce the signing of an authorized Canadian distribution agreement with OrCam for its MyEye 2 assistive technology device for the blind and visually impaired.
The OrCam MyEye 2 is a tiny, portable, artificial vision device for the blind and visually impaired that uses cutting-edge technology that is simple and intuitive. With its lightweight smart camera, it can instantly read written or digital text aloud, recognize faces, money notes, product labels and much more. Using simple hand gestures, its ease-of-use makes it ideal for children, adults and the elderly, no matter what level of vision they have. It can be used at home, at work or at school, and can also help people with learning disabilities, such as dyslexia.
Philipp Binder, Vice-President of I-MED Pharma stated, “The OrCam MyEye 2 is a fascinating device that offers a blind or visually impaired person of any age the ability to enjoy a book, recognize faces, identify products and so much more. It ultimately makes people feel more comfortable in social situations and gives them back their independence. We are proud to be able to offer this amazing assistive technology device to Canadians.”
Gil Artzyeli, VP Strategic Alliances at OrCam commented, “OrCam is proud to have I-Med-Pharma as its Canadian partner. OrCam’s cutting edge AI technology empowers the blind and visually impaired of all ages to be more independent, active and engaged. Together, with I-MED Pharma’s expertise in ophthalmology and optometry, we can reach out to thousands of Canadians who can benefit from the latest assistive technology available for the blind and visually impaired.”
I-MED Pharma is a privately held Canadian company, headquartered in Montreal, Quebec, servicing Canadian ophthalmologists, optometrists and the global eye care community. Established thirty years ago, I-MED Pharma Inc. creates and distributes innovative medical, surgical and veterinary eye care products. It continually researches, develops and sources the most effective and advanced solutions to eye disorders like cataracts, corneal degenerations, glaucoma, dry eye and meibomian gland disease.
I-MED Pharma is proud to have been at the forefront of managing Dry Eye Syndrome as a serious disease and invests heavily in researching and developing effective dry eye products. I-MED Pharma’s ocular surface disease product range includes dry eye drops, ocular hygiene, nutrition, therapeutic accessories and ocular occlusion devices.
OrCam’s mission is to harness the power of artificial vision by incorporating pioneering technology into a wearable platform which improves the lives of individuals who are blind, visually impaired, and have reading difficulties. OrCam was jointly founded in 2010 by Prof. Amnon Shashua and Mr. Ziv Aviram, who are also the co-founders of Mobileye, the collision avoidance system leader and autonomous driving innovator.